234 related articles for article (PubMed ID: 25910538)
21. Extracorporeal Photopheresis for Non-skin GvHD.
Bittenbring J; Reichrath J
Anticancer Res; 2016 Mar; 36(3):1395-6. PubMed ID: 26977041
[TBL] [Abstract][Full Text] [Related]
22. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
[TBL] [Abstract][Full Text] [Related]
23. [Extracorporeal photopheresis].
Hsieh A; Cortés B
Rev Med Suisse; 2018 Mar; 14(600):699-702. PubMed ID: 29589657
[TBL] [Abstract][Full Text] [Related]
24. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
25. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
26. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
Kaloyannidis P; Mallouri D
Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
[TBL] [Abstract][Full Text] [Related]
27. Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
Taverna F; Coluccia P; Arienti F; Birolini A; Terranova L; Mazzocchi A; Rini F; Mariani L; Melani C; Ravagnani F
J Clin Apher; 2015 Jun; 30(3):162-70. PubMed ID: 25220858
[TBL] [Abstract][Full Text] [Related]
28. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations.
DeSimone RA; Schwartz J; Schneiderman J
J Clin Apher; 2017 Dec; 32(6):543-552. PubMed ID: 28304115
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA).
Kaynar L; Tekgunduz E; Kozanoglu I; Ozkan HA; Aksu S; Ozkalemkas F; Demirkan F
Transfus Apher Sci; 2022 Feb; 61(1):103373. PubMed ID: 35123893
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic potential of extracorporeal photopheresis.
Girardi M
Clin Adv Hematol Oncol; 2006 May; 4(5):349-50. PubMed ID: 16728944
[No Abstract] [Full Text] [Related]
33. Extracorporeal photopheresis for graft-vs-host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group.
Nygaard M; Wichert S; Berlin G; Toss F
Eur J Haematol; 2020 May; 104(5):361-375. PubMed ID: 31908057
[TBL] [Abstract][Full Text] [Related]
34. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
Marshall SR
Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
[TBL] [Abstract][Full Text] [Related]
35. ECP and solid organ transplantation.
Jaksch P; Knobler R
Transfus Apher Sci; 2014 Jun; 50(3):358-62. PubMed ID: 24768429
[TBL] [Abstract][Full Text] [Related]
36. Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.
Baird K; Wayne AS
Transfus Apher Sci; 2009 Dec; 41(3):209-16. PubMed ID: 19819186
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
39. Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.
Schlaak M; Kurschat P; Shimabukuro-Vornhagen A; Scheid C; Chemnitz J; Stadler R; von Bergwelt-Baildon M; Theurich S
Transpl Immunol; 2011 Sep; 25(2-3):163-6. PubMed ID: 21745569
[TBL] [Abstract][Full Text] [Related]
40. Mode of action, indications and recommendations on extracorporeal photopheresis (ECP).
Cho A; Paulitschke V; Knobler R
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1369-1380. PubMed ID: 37723908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
